Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist interventions  Ruth L Taylor, MSc, Michael A Borger, MD, Richard.

Slides:



Advertisements
Similar presentations
Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia  Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.
Advertisements

The Myocardial Protective Effects of a Moderate-Potassium Blood Cardioplegia in Pediatric Cardiac Surgery: A Randomized Controlled Trial  Yang Liu, MD,
Differential Distribution of Lipid Microemboli After Cardiac Surgery
Incidence and Mechanisms of Cerebral Ischemia After Transcatheter Aortic Valve Implantation Compared With Surgical Aortic Valve Replacement  Aiman Alassar,
Fundus microvascular flow monitoring during retrograde cerebral perfusion: an experimental study  Peiqing Dong, MD, Yulong Guan, MD, Jing Yang, MD, Meiling.
Optimal flow rates for integrated cardioplegia
Randomized Comparison Between Normothermic and Hypothermic Cardiopulmonary Bypass in Pediatric Open-Heart Surgery  Massimo Caputo, MD, Simon Bays, Chris.
CTSNet: a unique educational vehicle
Shangyi Ji, MD, Jianan Yang, MD, Xiaoqing Ye, MD, Xiaolei Wang, MD 
James L Zellner, MD, Scott B Kribbs, BS, B
Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc, FRCSC, FACP, FACC 
Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes 
Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients  Jan Bucerius, MD, Jan F Gummert, MD, PhD, Michael A Borger,
Penehyclidine hydrochloride preserves the intestinal barrier function in patients undergoing cardiopulmonary bypass  Ying-jie Sun, PhD, Dan-dan Song,
Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit  Y.John Gu, MD, PhD, A.J de Vries, MD, Paulien Vos, Piet.
Sivelestat Attenuates Lung Injury in Surgery for Congenital Heart Disease With Pulmonary Hypertension  Norikazu Nomura, MD, PhD, Miki Asano, MD, PhD,
Current determinants of operative mortality in 1400 patients requiring aortic valve replacement  Ines Florath, PhD, Ulrich P Rosendahl, MD, Amir Mortasawi,
Surgical intervention criteria for thoracic aortic aneurysms: a study of growth rates and complications  Michael A Coady, MD, John A Rizzo, PhD, Graeme.
How safe is the port access technique in minimally invasive coronary artery bypass grafting?  Selami Dogan, MD, Kai Graubitz, MD, Tayfun Aybek, MD, Mohammad.
Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only  Thierry P Carrel, MD, Mike Schwanda, MD,
Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD 
Surgical treatment of the dilated ascending aorta: when and how?
Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all  David Faraoni, MD,
Increased intracerebral excitatory amino acids and nitric oxide after hypothermic circulatory arrest  Elaine E Tseng, MD, Malcolm V Brock, MD, Christopher.
Intraoperative myocardial protection: current trends and future perspectives  Gideon Cohen, MD, Michael A Borger, MD, Richard D Weisel, MD, Vivek Rao,
Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia  Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.
Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma
Wolfgang Harringer, MD  The Annals of Thoracic Surgery 
Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response  Martin Westerberg, MD, Anders.
Abdelsalam M. Elhenawy, MD, PhD, Christopher M
Nitecapone as an additive to crystalloid cardioplegia in patients who had coronary artery bypass grafting  Antti E Vento, MD, Juha Aittomäki, MD, Kalervo.
Traumatic tricuspid valve regurgitation and cerebral emboli
Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery  Torsten Doenst, MD, PhD,
Benjamin C. Sun, MD, Timothy A. Dickinson, CCP, Eric A
Solid and gaseous cerebral microembolization during off-pump, on-pump, and open cardiac surgery procedures  Yasir Abu-Omar, MRCS, Lognathen Balacumaraswami,
Christopher M. Feindel, MD, MSc, Maral Ouzounian, MD, PhD 
Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery  Julio C Vasquez, MD, Anna Vichiendilokkul, PharmD, Syed Mahmood, MD,
Platelet and Neutrophil Activation During Cardiac Surgical Procedures: Impact of Cardiopulmonary Bypass  David S Morse, David Adams, Barbarajean Magnani 
Individualized heparin and protamine management in infants and children undergoing cardiac operations  Massimiliano Codispoti, MD, Christopher A Ludlam,
Nilanjan Chaudhuri, Mark St.J Hickey  The Annals of Thoracic Surgery 
Insulin cardioplegia for elective coronary bypass surgery
Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery  Vivek Rao, MD, PhD, Joan Ivanov, RN, MSc, Richard.
Beneficial effects of ischemic preconditioning on right ventricular function after coronary artery bypass grafting  Zhong-Kai Wu, MD, Matti R Tarkka,
Neurocognitive Function and Cerebral Emboli: Randomized Study of On-Pump Versus Off-Pump Coronary Artery Bypass Surgery  Reza Motallebzadeh, MRCS, J.
Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair  Greg Stratmann, MD, PhD, Isobel A Russell,
Minimal access aortic valve replacement: effects on morbidity and resource utilization  Nicolas Doll, MD, Michael A Borger, MD, PhD, Joerg Hain, Jan Bucerius,
Cerebral Emboli and Serum S100β During Cardiac Operations
Cooling Gradients and Formation of Gaseous Microemboli With Cardiopulmonary Bypass: An Echocardiographic Study  Hans J Geissler, Steven J Allen, Uwe Mehlhorn,
Emergency cannulation for proximal perfusion in descending thoracic aorta procedures  Eugenio Neri, MD, Gianni Capannini, MD, Enrico Carone, MD, Enrico.
Sunil K. Ohri, Christopher W. Bowles, Robert T. Mathie, David R
The future of cardiac surgery training: A survival guide
Randomized Controlled Trial of Pericardial Blood Processing With a Cell-Saving Device on Neurologic Markers in Elderly Patients Undergoing Coronary Artery.
Coronary bypass and carotid endarterectomy: does a combined approach increase risk? A metaanalysis  Michael A Borger, MD, Stephen E Fremes, MD, Richard.
Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization  Paul Kurlansky, MD, Morley Herbert, PhD, Syma.
Neuropsychologic impairment after coronary bypass surgery: Effect of gaseous microemboli during perfusionist interventions  Michael A. Borger, MD, Charles.
Advances in the heart-lung machine after John and Mary Gibbon
A special adapted retractor for the mini-sternotomy approach
Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient 
Factors influencing intensive care unit length of stay after surgery for acute aortic dissection type A  Daniel Hoefer, MD, Elfriede Ruttmann, MD, Markus.
Roderick W Landymore, MD, Alexander J Bayes, MD, J
Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS 
The Impact of New Technology on Cardiothoracic Surgical Practice
Frank G. Scholl, MD, David Webb, CCP, Karla Christian, MD, Davis C
Aortic root replacement versus aortic valve replacement: a case-match study  Paul P Urbanski, MD, Matthias Wagner, MD, Michael Zacher, MD, Robert W Hacker,
Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury  Christine S Rinder, MD, Manuel Fontes, MD,
Thanos Sioris, MD, Tirone E
Karl A. Bocchieri, BS, CCP, S. Jacob Scheinerman, MD, L
Safety of low hematocrits during cardiopulmonary bypass
Y.John Gu, MD, PhD, Piet W. Boonstra, MD, PhD, Willem van Oeveren, PhD 
Christopher M Feindel, MD, Yong Sung, MD 
Presentation transcript:

Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist interventions  Ruth L Taylor, MSc, Michael A Borger, MD, Richard D Weisel, MD, Ludwig Fedorko, MD, PhD, Christopher M Feindel, MD  The Annals of Thoracic Surgery  Volume 68, Issue 1, Pages 89-93 (July 1999) DOI: 10.1016/S0003-4975(99)00475-0

Fig 1 Rate of microemboli detection during surgical interventions, perfusionist interventions, and baseline (see text for definitions). Perfusionist interventions resulted in a significantly higher rate of emboli production. The Annals of Thoracic Surgery 1999 68, 89-93DOI: (10.1016/S0003-4975(99)00475-0)

Fig 2 Proportion of total microemboli detected during each event. Drug injections and blood sampling (perfusionist interventions) resulted in a higher proportion of emboli than other events. (Aorta cann, Aorta decann = aortic cannulation and decannulation; CPB = cardiopulmonary bypass; Eject = start of cardiac ejection after cross-clamp removal; XCL = cross-clamp.) The Annals of Thoracic Surgery 1999 68, 89-93DOI: (10.1016/S0003-4975(99)00475-0)

Fig 3 Rate of microemboli detection during each surgical intervention. Initiation of cardiopulmonary bypass (CPB on) and start of cardiac ejection after cross-clamp removal (Eject) resulted in higher rates of emboli production than other surgical events. Other abbreviations are the same as in Figure 2. The Annals of Thoracic Surgery 1999 68, 89-93DOI: (10.1016/S0003-4975(99)00475-0)

Fig 4 Rate of microemboli detection during perfusionist interventions. Drug injection resulted in a higher rate of emboli production than blood sampling or any other period examined. The Annals of Thoracic Surgery 1999 68, 89-93DOI: (10.1016/S0003-4975(99)00475-0)